Naz Rahman
Stock Analyst at Maxim Group
(0.28)
# 4,050
Out of 4,784 analysts
40
Total ratings
16.13%
Success rate
-43.43%
Average return
Main Sectors:
Stocks Rated by Naz Rahman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLXN Silexion Therapeutics | Maintains: Buy | $9 → $5 | $1.17 | +327.35% | 2 | Mar 20, 2025 | |
| SCPH scPharmaceuticals | Maintains: Buy | $20 → $12 | $2.78 | +332.43% | 3 | Mar 20, 2025 | |
| VKTX Viking Therapeutics | Maintains: Buy | $120 → $70 | $25.65 | +172.90% | 5 | Feb 7, 2025 | |
| NRSN NeuroSense Therapeutics | Downgrades: Hold | n/a | $1.00 | - | 2 | Dec 16, 2024 | |
| CING Cingulate | Upgrades: Buy | n/a | $4.35 | - | 4 | Nov 20, 2024 | |
| PALI Palisade Bio | Maintains: Buy | $23 → $8 | $0.69 | +1,061.61% | 7 | Nov 13, 2024 | |
| PRFX PainReform | Downgrades: Hold | n/a | $2.17 | - | 2 | Oct 24, 2024 | |
| VRPX Virpax Pharmaceuticals | Downgrades: Hold | n/a | $1.34 | - | 4 | Oct 9, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $3 | $0.69 | +333.71% | 1 | Jul 26, 2024 | |
| QNRX Quoin Pharmaceuticals | Maintains: Buy | $15 → $4 | $0.24 | +1,554.26% | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $492.69 | - | 1 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $0.09 | +4,551.16% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.39 | - | 3 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.21 | +313.22% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.03 | - | 1 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $2.88 | +108.33% | 1 | Feb 25, 2022 |
Silexion Therapeutics
Mar 20, 2025
Maintains: Buy
Price Target: $9 → $5
Current: $1.17
Upside: +327.35%
scPharmaceuticals
Mar 20, 2025
Maintains: Buy
Price Target: $20 → $12
Current: $2.78
Upside: +332.43%
Viking Therapeutics
Feb 7, 2025
Maintains: Buy
Price Target: $120 → $70
Current: $25.65
Upside: +172.90%
NeuroSense Therapeutics
Dec 16, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.00
Upside: -
Cingulate
Nov 20, 2024
Upgrades: Buy
Price Target: n/a
Current: $4.35
Upside: -
Palisade Bio
Nov 13, 2024
Maintains: Buy
Price Target: $23 → $8
Current: $0.69
Upside: +1,061.61%
PainReform
Oct 24, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.17
Upside: -
Virpax Pharmaceuticals
Oct 9, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.34
Upside: -
Assertio Holdings
Jul 26, 2024
Initiates: Buy
Price Target: $3
Current: $0.69
Upside: +333.71%
Quoin Pharmaceuticals
Mar 15, 2024
Maintains: Buy
Price Target: $15 → $4
Current: $0.24
Upside: +1,554.26%
Jan 31, 2024
Downgrades: Hold
Price Target: n/a
Current: $492.69
Upside: -
Dec 8, 2023
Initiates: Buy
Price Target: $4
Current: $0.09
Upside: +4,551.16%
Nov 17, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.39
Upside: -
Aug 9, 2023
Initiates: Buy
Price Target: $5
Current: $1.21
Upside: +313.22%
May 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.03
Upside: -
Feb 25, 2022
Initiates: Buy
Price Target: $6
Current: $2.88
Upside: +108.33%